← FDA DRUG APPROVALS

FDA ANDA · ANDA086184

SULFASALAZINE

Sponsor: EPIC PHARMA LLC

APPLICATION
ANDA086184
TYPE
ANDA
ORIGINAL APPROVAL
1994-09-16
LATEST ACTION
1994-09-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

SULFASALAZINEDiscontinued
SULFASALAZINE 500MG · TABLET · ORAL

Approval history

1994-09-16OriginalAP
1983-06-27Manufacturing (CMC) · Supplement 2AP
1983-04-01Manufacturing (CMC) · Supplement 4AP
1983-04-01Manufacturing (CMC) · Supplement 5AP
1983-04-01Manufacturing (CMC) · Supplement 3AP
1983-04-01Manufacturing (CMC) · Supplement 1AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →